Groupama Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.17M | Sell |
25,308
-14,373
| -36% | -$666K | 0.02% | 256 |
|
2025
Q1 | $2.38M | Sell |
39,681
-7,690
| -16% | -$462K | 0.05% | 166 |
|
2024
Q4 | $2.66M | Sell |
47,371
-16,208
| -25% | -$909K | 0.05% | 160 |
|
2024
Q3 | $2.64M | Sell |
63,579
-52,430
| -45% | -$2.18M | 0.07% | 151 |
|
2024
Q2 | $3.9M | Buy |
116,009
+59,814
| +106% | +$2.01M | 0.05% | 145 |
|
2024
Q1 | $5.86M | Sell |
56,195
-48,102
| -46% | -$5.02M | 0.11% | 129 |
|
2023
Q4 | $5.35M | Buy |
+104,297
| New | +$5.35M | 0.14% | 107 |
|